Guizhou Bailing Group Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of March 2019: 2.09%

Guizhou Bailing Group Pharmaceutical Co Ltd asset resilience ratio. Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has an Asset Resilience Ratio of 2.09% as of March 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Guizhou Bailing Group Pharmaceutical Co defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥138.84 Million

≈ $20.32 Million USD Cash + Short-term Investments

Total Assets

CN¥6.65 Billion

≈ $972.77 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Guizhou Bailing Group Pharmaceutical Co Ltd (2014–2014)

Asset resilience ratio of Guizhou Bailing Group Pharmaceutical Co Ltd from 2014 to 2014. This chart shows how Guizhou Bailing Group Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Guizhou Bailing Group Pharmaceutical Co (002424) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Guizhou Bailing Group Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Guizhou Bailing Group Pharmaceutical Co 's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥138.84 Million	2.09%
Total Liquid Assets	CN¥138.84 Million	2.09%

Asset Resilience Insights

Limited Liquidity: Guizhou Bailing Group Pharmaceutical Co Ltd maintains only 2.09% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guizhou Bailing Group Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guizhou Bailing Group Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	11.84%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.42%

Guizhou Bailing Group Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2014–2014)

Guizhou Bailing Group Pharmaceutical Co Ltd asset resilience ratio by year from 2014 to 2014. The table below shows the annual Asset Resilience Ratio data for Guizhou Bailing Group Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2014-12-31	2.80%	CN¥100.00 Million ≈ $14.63 Million	CN¥3.57 Billion ≈ $521.70 Million	--

pp = percentage points

About Guizhou Bailing Group Pharmaceutical Co Ltd

SHE:002424 China Drug Manufacturers - Specialty & Generic

Market Cap

$908.04 Million

CN¥6.21 Billion CNY

Market Cap Rank

#8960 Global

#2110 in China

Share Price

CN¥4.44

Change (1 day)

-0.89%

52-Week Range

CN¥4.09 - CN¥6.18

All Time High

CN¥28.52